Doganay HL - Search Results

1

The acute effect of different NAD⁺ precursors included in the combined metabolic activators.

Li X, Yang H, Jin H, Turkez H, Ozturk G, Doganay HL, Zhang C, Nielsen J, Uhlén M, Borén J, Mardinoglu A. Li X, et al. Among authors: doganay hl. Free Radic Biol Med. 2023 Aug 20;205:77-89. doi: 10.1016/j.freeradbiomed.2023.05.032. Epub 2023 Jun 2. Free Radic Biol Med. 2023. PMID: 37271226 Clinical Trial.

2

Longitudinal metabolomics analysis reveals the acute effect of cysteine and NAC included in the combined metabolic activators.

Yang H, Li X, Jin H, Turkez H, Ozturk G, Doganay HL, Zhang C, Nielsen J, Uhlén M, Borén J, Mardinoglu A. Yang H, et al. Among authors: doganay hl. Free Radic Biol Med. 2023 Aug 1;204:347-358. doi: 10.1016/j.freeradbiomed.2023.05.013. Epub 2023 May 26. Free Radic Biol Med. 2023. PMID: 37245532 Free article. Clinical Trial.

3

A comparison of antibody response in kidney transplant recipients and healthcare workers who had PCR-confirmed COVID-19 infection.

Dincer MT, Eren N, Murt A, Yıldız N, Özcan ŞG, Ergül M, Bek SG, Atlı Z, Trabulus S, Dervişoğlu E, Doğanay HL, Seyahi N. Dincer MT, et al. Among authors: doganay hl. Turk J Med Sci. 2022 Dec;52(6):1754-1761. doi: 10.55730/1300-0144.5520. Epub 2022 Dec 21. Turk J Med Sci. 2022. PMID: 36945967 Free PMC article.

4

Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial.

Tanriover MD, Aydin OA, Guner R, Yildiz O, Celik I, Doganay HL, Kose S, Akhan S, Akalin EH, Sezer Z, Ozdarendeli A, Unal S, On Behalf Of The Turkovac Study Group. Tanriover MD, et al. Among authors: doganay hl. Vaccines (Basel). 2022 Nov 4;10(11):1865. doi: 10.3390/vaccines10111865. Vaccines (Basel). 2022. PMID: 36366373 Free PMC article.

5

Characteristics of patients with hepatocellular carcinoma: A multicenter study.

Guzelbulut F, Karaogullarindan U, Akkiz H, Altintas E, Demirtas CO, Bahadir O, Keklikkiran C, Yildirim AE, Gumussoy M, Balci HR, Gokcen P, Gokce DT, Simsek C, Turan I, Can G, Gokbulut V, Yaras S, Adali G, Akdogan RA, Avcioglu U, Demir M, Doganay HL, Vatansever S, Sumer H, Dilber F, Kayhan MA, Balaban HY, Simsek H, Ozdogan OC, Akarca US, Karasu Z, Gunsar F, Idilman R. Guzelbulut F, et al. Among authors: doganay hl. Hepatol Forum. 2022 Sep 23;3(3):71-76. doi: 10.14744/hf.2022.2022.0028. eCollection 2022 Sep. Hepatol Forum. 2022. PMID: 36177097 Free PMC article.

6

Validation of the PAGE-B score to predict hepatocellular carcinoma risk in caucasian chronic hepatitis B patients on treatment.

Gokcen P, Guzelbulut F, Adali G, Degirmenci Salturk AG, Ozturk O, Bahadir O, Kanatsiz E, Kiyak M, Ozdil K, Doganay HL. Gokcen P, et al. Among authors: doganay hl. World J Gastroenterol. 2022 Feb 14;28(6):665-674. doi: 10.3748/wjg.v28.i6.665. World J Gastroenterol. 2022. PMID: 35317422 Free PMC article.

7

Immunohistochemical Evaluation of BAP1 Expression in Breast Cancer with Known BRCA1 and BRCA2 Mutations and Comparison with Histopathological Features.

Çalım-Gürbüz B, Güvendir İ, Ünal B, Erdoğan-Durmuş Ş, Topal CS, Ağaoğlu NB, Doğanay HL, Kızılboğa T, Zemheri IE. Çalım-Gürbüz B, et al. Among authors: doganay hl. Int J Surg Pathol. 2022 Jun;30(4):397-404. doi: 10.1177/10668969221085969. Epub 2022 Mar 9. Int J Surg Pathol. 2022. PMID: 35261270

8

CRISPR/Cas9-mediated Bag-1 knockout increased mesenchymal characteristics of MCF-7 cells via Akt hyperactivation-mediated actin cytoskeleton remodeling.

Kilbas PO, Can ND, Kizilboga T, Ezberci F, Doganay HL, Arisan ED, Dinler Doganay G. Kilbas PO, et al. Among authors: doganay hl. PLoS One. 2022 Jan 7;17(1):e0261062. doi: 10.1371/journal.pone.0261062. eCollection 2022. PLoS One. 2022. PMID: 34995286 Free PMC article.

9

CoronaVac efficacy data from Turkey - Authors' reply.

Tanriover MD, Doğanay HL, Unal S, Akova M. Tanriover MD, et al. Among authors: doganay hl. Lancet. 2021 Nov 20;398(10314):1874. doi: 10.1016/S0140-6736(21)02286-8. Lancet. 2021. PMID: 34801106 Free PMC article. No abstract available.

10

Can simple Non-Invasive Fibrosis Models Determine Prognostic Indicators (Fibrosis and Treatment Response) of Primary Biliary Cholangitis?

Sayar S, Gokcen P, Aykut H, Adali G, Doganay HL, Ozdil K. Sayar S, et al. Among authors: doganay hl. Sisli Etfal Hastan Tip Bul. 2021 Sep 24;55(3):412-418. doi: 10.14744/SEMB.2021.95825. eCollection 2021. Sisli Etfal Hastan Tip Bul. 2021. PMID: 34712085 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page